bit.bio is a pioneering biotechnology company specializing in cell programming technology. The company focuses on developing and commercializing advanced solutions that enable precise control over cell identity, with applications in research, drug discovery, and regenerative medicine.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$80M
Total Amount Raised$80M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.